health · humanitarian · family: the context you didn’t design for
donated, broken, unrepairable
40–96% of donated medical equipment in developing countries is out of service, and it often cannot be repaired locally
Problem statement
By some estimates, 40–96% of donated medical equipment in developing countries is out of service at any given time; the Lancet Commission notes that most of those analyses were not focused on diagnostic equipment and are not recent. Equipment is often donated or procured without service contracts, training and software-upgrade budgets, access to replacement parts, or consideration of local repair infrastructure. When devices fail — often because of inconsistent power supply, in settings where heat and humidity also work against equipment performance — local contractors rarely have the expertise to service the range of instruments in use, software updates are unavailable or unaffordable, and replacement parts cannot be sourced locally. The result is a large stock of non-functional equipment, some of it donated when already beyond the end of its normal service life in high-income countries, and without the maintenance ecosystem it depends on.
Why this matters
An estimated 47% of the global population — just under half — has little to no access to diagnostics. Diagnostics are the gateway to treatment: the Commission reports that about 30% of tuberculosis patients are not diagnosed or reported, and estimates that reducing the diagnostic gap for six tracer conditions to 10% would avert about 1.1 million premature deaths a year in low- and middle-income countries. The Lancet Commission names low political prioritisation as the key cause of poor access and calls for change in policy, governance, and finance and for the removal of barriers in infrastructure, workforce, and quality; in this brief's reading, the equipment-repair problem is the most tractable design challenge among them. The Commission concludes that donations of complex diagnostic equipment carry severe disadvantages and can make the situation worse.
What’s been tried and why it hasn’t worked
Equipment donation has been a mainstay of global efforts to widen access, and the Commission finds it can make the situation worse: donated equipment is often incomplete, and it can arrive beyond its normal service life, without manuals in a language staff can use, without compatible software updates, and without service contracts or access to qualified service engineers. Uncoordinated donations from different vendors multiply the platforms, supply chains, and training a health system has to support, and most countries lack mechanisms to track or inventory what they receive. Procurement tenders often leave out training and software upgrades to hold down the price, at the expense of quality over the long term. Where local technical support exists, contractors lack the expertise to service a wide variety of instruments and cannot get replacement parts locally; for complex equipment, buying third-party parts is common, which creates multiple supply chains and has adverse effects on warranties. WHO and others have identified the shortage of technology support, such as biomedical engineers, as a crucial gap, and rules meant to secure accountability for maintenance (such as requiring a local distributor) can inflate costs in small markets with little competition.
What would unlock progress
Devices designed from the outset with modular, field-replaceable components, open-source diagnostic firmware, and locally manufacturable spare parts would dramatically extend equipment lifespan in LMIC settings. Design-for-repair standards — analogous to IP-rated environmental protection ratings — could create a measurable repairability index for medical equipment procurement decisions. Even simple interventions (standardized power supplies across device families, common fasteners, QR-code-linked repair guides) could reduce the non-functional rate significantly.
Entry points for student teams
A student team could conduct a teardown analysis of 2–3 commonly donated diagnostic devices (e.g., portable ultrasound, hematology analyzer, pulse oximeter), document failure modes from published BMET repair logs, identify which components fail most frequently, and redesign those components for field replaceability using locally available materials and tools. Alternatively, teams could develop a "repairability scorecard" for medical equipment, analogous to iFixit's repairability scoring, and apply it to WHO Essential Diagnostics List devices. Relevant disciplines: product design, biomedical engineering, mechanical engineering, global health.
Genes
Structural cousins: stuck the same way, in other fields
Sources
Fleming, K.A. et al., "The Lancet Commission on diagnostics: transforming access to diagnostics," The Lancet, 398, 1997–2050, 2021, )00673-5/fulltext; accessed 2026-02-20 go to source ↗
Working notes
Notes made while writing and checking this brief, shown as written. They use working shorthand.
Related briefs: `health-neonatal-cpap-low-resource-failure` (specific device failure in LMICs — this brief addresses the systemic design-for-repairability gap across all medical equipment); `health-neonatal-jaundice-phototherapy-lmic` (another specific device); `health-oxygen-concentrator-low-resource-failure` (another specific device). This brief deliberately does NOT apply `constraint:technical` — the devices themselves work; the barrier is that they were designed without considering the maintenance ecosystem of their deployment context. Source-bias note: the Lancet Commission frames this primarily as a policy/investment failure, but the design constraint is equally binding and more tractable for student teams.
Reconciliation 2026-09-30: Fact repair after reading the whole write-up against its one source, the Lancet Commission on diagnostics (Fleming et al. 2021); a second reader went over every repair on the same day, confirmed each against the same text, and tightened the wording of several. The publisher page blocks scripts, so the full text was read on 2026-09-30 from the open PubMed Central copy through Europe PMC (https://www.ebi.ac.uk/europepmc/webservices/rest/PMC8494468/fullTextXML, PMC8494468; full text, about 49,000 words including references). The citation on the Source line (authors, title, The Lancet, volume 398, pages 1997–2050, 2021) matches the Europe PMC record. (1) The long title and the opening sentence said "approximately 40%" of medical diagnostic equipment in developing countries is out of service, "compared to less than 1% in high-income countries". The Commission says (Panel 4): "By some estimates, 40–96% of donated medical equipment is at any point in time out of service, although most analyses of this issue were not focused on diagnostic equipment and are not recent." It gives no high-income comparison. The title and the sentence now give the 40–96% range, say "donated", carry the Commission's caveat, and the "less than 1%" comparison is gone. The title's stated cause ("Because It Was Not Designed for Local Repair") is not in the source, which lists many reasons donated equipment fails; the title now says it "often cannot be repaired locally", which the Commission does say (local contractors lack the expertise and the replacement parts; service contracts and qualified service engineers are scarce). Old title: "40% of Medical Equipment in Developing Countries Is Non-Functional Because It Was Not Designed for Local Repair". New title: "40–96% of Donated Medical Equipment in Developing Countries Is Out of Service, and It Often Cannot Be Repaired Locally". The Display title did not change. (2) "Power surges, dust, humidity, or consumable stockouts" as failure causes: the Commission says inconsistent power supply "often leads to frequent breakdowns", and that control of high temperatures and humidity is "necessary for optimal performance" of equipment; dust and consumable stockouts are not in it. The sentence now names inconsistent power supply as the failure cause and says heat and humidity work against equipment performance. "No access to proprietary diagnostic software" became "software updates are unavailable or unaffordable", which is what the source says. "Designed for the infrastructure and maintenance ecosystems of wealthy countries" became "some of it donated when already beyond the end of its normal service life in high-income countries", from the Commission's "can result in donation of equipment that is well beyond the normal end of service". (3) "3.6 billion people" is not in the source; the 47% figure is, and the Commission's own gloss "just under half" replaced the number. (4) "Tuberculosis, malaria, and cervical cancer go untreated even when therapeutics are available" is not in the source (on malaria it says the opposite problem, clinical over-diagnosis). The sentence now carries two figures the Commission gives: it reports that about 30% of tuberculosis patients are not diagnosed or reported, and estimates that reducing the diagnostic gap for six tracer conditions to 10% would avert 1·1 million premature deaths a year in low- and middle-income countries. (5) "Nine interlocking market failures" is not in the source; the Commission names low political prioritisation as the key cause of poor access and proposes change in policy, governance, and finance and the removal of barriers in infrastructure, workforce, and quality. The sentence now says that, and marks "most tractable design challenge" as this brief's own reading. (6) "Millions of dollars of donated equipment becomes non-functional within 2–5 years" is not in the source and was replaced with the Commission's conclusion that donations of complex diagnostic equipment carry severe disadvantages and can make the situation worse. (7) The "What's Been Tried" section rested on claims that are not in the source: WHO/UNICEF Target Product Profiles, GeneXpert, a 30–60% attrition rate for biomedical equipment technician programmes, and the right-to-repair movement. None was re-sourced; the section now describes what the Commission itself reports has been tried and why it falls short (donation as "a mainstay" with its facility- and system-level problems from Panel 4, tenders that omit training and software upgrades, third-party parts for complex equipment with "adverse effects on warranties", the local-distributor rule, the shortage of biomedical engineers), with the Commission's own hedges kept ("often incomplete", "can result in", "might not be available"). Confirmed in the source and left as written: the 2018 WHO Essential Diagnostics List; the Commission framing access primarily as a political-prioritisation and investment problem (Source Notes). Not checked, because they are proposals or analogies rather than claims about the source: the "What Would Unlock Progress" section, the iFixit and IP-rating comparisons, and "published BMET repair logs" in the entry points, whose existence this pass did not test.